Hummingbird targets antibody discovery hurdle in fighting cancer
Sharanya Pillai
Singapore
ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying cancer cells.
But the industry bottleneck is that once researchers identify a good target protein, it is difficult to find the right antibodies to act against it.
TRENDING NOW
Once staunchly pro-China, Malaysian Chinese businesses are now distancing themselves from Beijing
Stocks to watch: HPL, Aims Apac Reit, Zico, Advanced Systems Automation, ComfortDelGro
‘How many will survive?’: Bubble fears arise as China’s humanoid robotics face reality check
Smaller board lots can’t fix a market run by three banks